journal article·2025-11

Quaternary Nanobomb Triggered Ferroptosis and Pyroptosis Enhance Immunogenicity and Immunotherapy of Triple Negative Breast Cancer

Tao Lu, Wangran Wu, Hongyican Chen, Qingxue Zuo, Huijuan Wu, Shujing Zhao, Jinfeng Wang, Xiao Zhi, Chenguo Zheng, Mingdong Lu, Chao Li

Small· Volume 21· Issue 44
Publisher page

Abstract

Abstract Reversing immunosuppressive “cold” tumor into immunoresponsive “hot” tumor is the principle for immunotherapy of immunosuppressive tumors, such as triple‐negative breast cancer (TNBC). In this study, the “Quaternary Nanobomb” of MnO 2 ‐shelled Chlorin e6 (Ce6), Polydopamine (PDA), Arginine (Arg), and CO 2 is prepared, namely BCPA‐CO 2 @MnO 2 . In the weakly acidic tumor microenvironment (TME) or the lysosome of TNBC cells (4T1 cell line), MnO 2 is rapidly degraded to Mn 2+ , while CO 2 and the large number of guanidine‐mediated proton sponge effects (PSE) accelerate the “explosive release” of Ce6 and PDA. The result demonstrates that the BCPA‐CO 2 @MnO 2 disrupts intracellular ion homeostasis and exerts glutathione oxidase (GSH‐Ox), catalase (CAT), and peroxidase‐like activities, thereby accelerating the process of ferroptosis in 4T1 cells. Under dual near‐infrared (NIR) irradiation (660 and 808 nm), the pyroptosis and immunogenic cell death (ICD) are effectively triggered by the nascent reactive oxygen species (ROS), reactive nitrogen species (RNS), and thermal effects. Ferroptosis, pyroptosis, Mn 2+ , and ICD‐mediated damage‐associated molecular patterns (DAMPs) release synergistically activate the cGAS‐STING pathway, innate/adaptive immunity, thereby boosting TNBC immunogenicity and immune memory to enhance immunotherapy efficacy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · RNA modifications and cancer · Cancer Immunotherapy and Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University 109 Xueyuan West Road Wenzhou Zhejiang 325027 P. R. China

Shanghai Institute of Virology Shanghai Jiao Tong University School of Medicine 227 South Chongqing Road Shanghai 200225 P. R. China

Funding

National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.3892/ol.2021.1277310.3892/ol.2021.12773 ↗
2. 10.34133/research.047210.34133/research.0472 ↗
3. 10.1016/j.semcancer.2020.06.00510.1016/j.semcancer.2020.06.005 ↗
4. 10.1016/j.drup.2024.10106310.1016/j.drup.2024.101063 ↗
5. Kong X. · Cancer Biol. Med. · 2024 · 22
6. 10.1016/j.jconrel.2025.01.01410.1016/j.jconrel.2025.01.014 ↗
7. 10.1002/advs.20220002710.1002/advs.202200027 ↗
8. 10.1186/s12943-021-01317-710.1186/s12943-021-01317-7 ↗
9. 10.1038/s41551-024-01221-710.1038/s41551-024-01221-7 ↗
10. 10.1016/j.nantod.2022.10140510.1016/j.nantod.2022.101405 ↗
11. 10.1002/ange.20241080310.1002/ange.202410803 ↗
12. 10.1021/acsnano.3c1024910.1021/acsnano.3c10249 ↗
13. 10.1002/adma.20231321210.1002/adma.202313212 ↗
14. 10.1021/acsnano.4c0432210.1021/acsnano.4c04322 ↗
15. 10.1016/j.cej.2023.14136910.1016/j.cej.2023.141369 ↗
16. 10.1002/smll.20230640210.1002/smll.202306402 ↗
17. 10.1016/j.biomaterials.2022.12150310.1016/j.biomaterials.2022.121503 ↗
18. 10.1002/EXP.2024027510.1002/EXP.20240275 ↗
19. 10.1002/adma.20231096410.1002/adma.202310964 ↗
20. 10.1021/acsnano.3c1181810.1021/acsnano.3c11818 ↗
21. 10.1021/acsnano.3c0949910.1021/acsnano.3c09499 ↗
22. 10.1021/acsnano.8b0515110.1021/acsnano.8b05151 ↗
23. 10.1002/adma.20230409810.1002/adma.202304098 ↗
24. 10.1016/j.biomaterials.2023.12243510.1016/j.biomaterials.2023.122435 ↗
25. 10.1021/nn404117j10.1021/nn404117j ↗
26. 10.1016/j.actbio.2021.09.01410.1016/j.actbio.2021.09.014 ↗
27. 10.1021/acsami.8b1704110.1021/acsami.8b17041 ↗
28. 10.2147/IJN.S34750610.2147/IJN.S347506 ↗
29. 10.1016/j.biomaterials.2022.12144810.1016/j.biomaterials.2022.121448 ↗
30. 10.1016/j.tetlet.2016.11.04610.1016/j.tetlet.2016.11.046 ↗
31. 10.1016/j.nantod.2022.10140610.1016/j.nantod.2022.101406 ↗
32. 10.1016/j.cogsc.2023.10079310.1016/j.cogsc.2023.100793 ↗
33. 10.1021/acs.analchem.1c0178710.1021/acs.analchem.1c01787 ↗
34. 10.1021/jacs.7b0555910.1021/jacs.7b05559 ↗
35. 10.1016/j.biomaterials.2023.12203110.1016/j.biomaterials.2023.122031 ↗
36. 10.1002/smll.20230305710.1002/smll.202303057 ↗
37. 10.1002/anie.20221915310.1002/anie.202219153 ↗
38. 10.1016/j.apsb.2024.05.00710.1016/j.apsb.2024.05.007 ↗
39. 10.1038/s41467-020-15003-710.1038/s41467-020-15003-7 ↗
40. 10.1155/2022/645958510.1155/2022/6459585 ↗
41. 10.1002/anie.20230301010.1002/anie.202303010 ↗
42. 10.1016/j.phrs.2022.10653310.1016/j.phrs.2022.106533 ↗
43. 10.1021/acsami.3c0176210.1021/acsami.3c01762 ↗
44. 10.1111/acel.1430310.1111/acel.14303 ↗
45. 10.1002/advs.20230544210.1002/advs.202305442 ↗
46. 10.1016/j.molimm.2020.07.00210.1016/j.molimm.2020.07.002 ↗
47. 10.1016/j.cellimm.2021.10431210.1016/j.cellimm.2021.104312 ↗
48. 10.3390/vaccines1102021810.3390/vaccines11020218 ↗
49. Sun J. · Int. J. Mech. Sci. · 2024 · 25 · 3735
50. 10.1038/s41416-021-01338-510.1038/s41416-021-01338-5 ↗
51. 10.1007/s11427-023-2499-210.1007/s11427-023-2499-2 ↗
52. 10.1002/adma.20241507810.1002/adma.202415078 ↗